A 63-year-old woman with Type 2 diabetes is seen for follow-up after a fasting lipid profile. She has no other medical conditions and feels well. Her diabetes is well controlled and the last hemoglobin A1C value was 6.5%. Her total cholesterol (T-chol) is 240 mg/dL, HDL50 mg/dL, low-density lipoprotein (LDL) 160 mg/dL, and triglycerides 150 mg/dL.For the above patient with dyslipidemia, select the most appropriate treatment.
A 63-year-old woman with Type 2 diabetes is seen for follow-up after a fasting lipid profile. She has no other medical conditions and feels well. Her diabetes is well controlled and the last hemoglobin A1C value was 6.5%. Her total cholesterol (T-chol) is 240 mg/dL, HDL50 mg/dL, low-density lipoprotein (LDL) 160 mg/dL, and triglycerides 150 mg/dL.For the above patient with dyslipidemia, select the most appropriate treatment.
💡 Explanation
**Core Concept**
The patient has dyslipidemia with elevated total cholesterol, LDL, and triglycerides, while having a relatively low HDL. This presentation is consistent with mixed dyslipidemia, a common condition in patients with Type 2 diabetes.
**Why the Correct Answer is Right**
The patient's dyslipidemia is a major risk factor for cardiovascular disease. Given her well-controlled diabetes and relatively low HDL, the primary goal of treatment is to reduce her LDL and triglyceride levels while also considering her HDL levels. Statins are the first-line treatment for reducing LDL levels. In this case, the patient's LDL level is 160 mg/dL, which is above the recommended goal of <100 mg/dL for patients with diabetes. Additionally, her triglyceride level is elevated, which can be addressed with a fibrate or a combination of a statin and a fibrate.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the patient's elevated LDL and triglyceride levels. While the patient's HDL level is low, this option does not provide a comprehensive treatment plan.
**Option B:** This option is incorrect because it does not address the patient's elevated LDL and triglyceride levels. While the patient's HDL level is low, this option does not provide a comprehensive treatment plan.
**Option C:** This option is incorrect because it does not address the patient's elevated LDL and triglyceride levels. While the patient's HDL level is low, this option does not provide a comprehensive treatment plan.
**Option D:** This option is incorrect because it does not address the patient's elevated LDL and triglyceride levels. While the patient's HDL level is low, this option does not provide a comprehensive treatment plan.
**Clinical Pearl / High-Yield Fact**
In patients with Type 2 diabetes, the primary goal of lipid-lowering therapy is to reduce cardiovascular risk. Statins are the first-line treatment for reducing LDL levels, and fibrates can be added to address elevated triglyceride levels.
**Correct Answer:** A.
✓ Correct Answer: D. hepatic hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (lovastatin, simvastatin, pravastatin)
📤 Share this MCQ
Share Card Preview
👆 1080x1080 square card — fills the full width in WhatsApp and Telegram